外泌体miRNA在肺结核诊断中的研究进展
Research Progress about miRNA of Exosomes in the Diagnosis of Pulmonary Tuberculosis
DOI: 10.12677/ACM.2023.1371602, PDF,   
作者: 马 琦：青海大学研究生院，青海 西宁；久 太：青海大学附属医院呼吸与危重症医学科，青海 西宁
关键词: 肺结核；外泌体；miRNA；生物标志物；结核分枝杆菌；Pulmonary Tuberculosis； Exosomes； miRNA； Biomarkers； Mycobacterium tuberculosis
摘要: 来自细胞外囊泡的微RNA (miRNA)，长度约为22个核酸，不参与单链RNA的编码。它们参与调节转录后的基因表达，并在调节免疫系统方面发挥重要作用。近些年，很多关于miRNA与结核病之间的研究表明miRNA在结核病的发生发展上发挥重要作用，为结核病的诊断与鉴别诊断以及发病机制的研究提供了潜在的可能。本文将针对外泌体来源的miRNA在肺结核诊断中的研究现状做一个综述。
Abstract: miRNAs from extracellular vesicles are a class of substances that do not encode single stranded RNA, with a length of approximately 22 nucleic acids. They participate in regulating gene expression af-ter transcription and play an important role in regulating the immune system. In recent years, many studies on the relationship between miRNA and tuberculosis have shown that miRNA plays an important role in the occurrence and development of tuberculosis, providing potential possibili-ties for the diagnosis and differential diagnosis of tuberculosis and the study of pathogenesis. This article provides a review of the current research status of miRNAs derived from extracellular vesi-cles in the diagnosis of pulmonary tuberculosis.
文章引用：马琦, 久太. 外泌体miRNA在肺结核诊断中的研究进展[J]. 临床医学进展, 2023, 13(7): 11462-11467. https://doi.org/10.12677/ACM.2023.1371602

参考文献

[1] World Health Organization (2018) Global Tuberculosis Report 2018.
[2] World Health Organization (2019) Global Tuberculosis Report 2019.
[3] Narasimhan, P., Wood, J., Macintyre, C.R. and Mathai, D. (2013) Risk Factors for Tu-berculosis. Pulmonary Medicine, 2013, Article ID: 828939. [Google Scholar] [CrossRef] [PubMed]
[4] Bhatt, K. and Salgame, P. (2007) Host Innate Immune Response to Mycobacterium Tuberculosis. Journal of Clinical Immunology, 27, 347-362. [Google Scholar] [CrossRef] [PubMed]
[5] Liu, P.T. and Modlin, R.L. (2008) Human Macrophage Host Defense against Mycobacterium Tuberculosis. Current Opinion in Immunology, 20, 371-376. [Google Scholar] [CrossRef] [PubMed]
[6] Frahm, M., Goswami, N., Owzar, K., et al. (2011) Discriminating between Latent and Active Tuberculosis with Multiple Biomarker Responses. Tuberculosis, 91, 250-256. [Google Scholar] [CrossRef] [PubMed]
[7] Lin, J., Li, J., Huang, B., et al. (2015) Review Article Exosomes: Novel Biomarkers for Clinical Diagnosis. The Scientific World Journal, 2015, Article ID: 657086. [Google Scholar] [CrossRef] [PubMed]
[8] Raposo, G. and Stoorvogel, W. (2013) Extracellular Vesicles: Exosomes, Microvesicles, and Friends. Journal of Cell Biology, 200, 373-383. [Google Scholar] [CrossRef] [PubMed]
[9] Cheng, L., Sharples, R., Scicluna, B.J. and Hill, A.F. (2014) Exosomes Provide a Protective and Enriched Source of miRNA for Biomarker Profiling Compared to Intracellular and Cell-Free Blood. Journal of Extracellular Vesicles, 3, Article 23743. [Google Scholar] [CrossRef] [PubMed]
[10] Mathivanan, S. and Simpson, R.J. (2009) ExoCarta: A Compendium of Exosomal Proteins and RNA. Proteomics, 9, 4997-5000. [Google Scholar] [CrossRef] [PubMed]
[11] Tickner, J.A., Urquhart, A.J., Stephenson, S.A., Richard, D.J. and O’Byrne, K.J. (2014) Functions and Therapeutic Roles of Exosomes in Cancer. Frontiers in Oncology, 4, Article 127. [Google Scholar] [CrossRef] [PubMed]
[12] Sun, T., Kalionis, B., Lv, G.Y., Xia, S.J. and Gao, W. (2015) Role of Exosomal Noncoding RNAs in Lung Carcinogenesis. Biomed Research International, 2015, Article ID 125807. [Google Scholar] [CrossRef] [PubMed]
[13] Eldh, M. (2013) Exosomes and Exosomal RNA—A Way of Cell-to-Cell Communication. Master’s Thesis, Sahlgrenska Academy at University of Gothenburg, Göteborg.
[14] Drain, P.K., Ba-jema, K.L., Dowdy, D., et al. (2018) Incipient and Subclinical Tuberculosis: A Clinical Review of Early Stages and Pro-gression of Infection. Clinical Microbiology Reviews, 31. [Google Scholar] [CrossRef] 
[15] Abel, L., Fellay, J., Haas, D., et al. (2018) Genetics of Human Susceptibility to Active and Latent Tuberculosis: Present Knowledge and Future Perspectives. The Lancet Infectious Diseases, 18, E64-E75. [Google Scholar] [CrossRef] 
[16] Guo, W.R., Li, J.T., Pan, X., Wei, L.P. and Wu, J.Y. (2010) Candidate Mycobacterium Tuberculosis Genes Targeted by Human MicroRNAs. Protein & Cell, 1, 419-421. [Google Scholar] [CrossRef] [PubMed]
[17] Bhatnagar, S. and Schorey, J. (2007) Exosomes Released from Infected Macrophages Contain Mycobacterium avium Glycopeptidolipids and Are Proinflammatory. Journal of Biologi-cal Chemistry, 282, 25779-25789. [Google Scholar] [CrossRef] 
[18] Bhatnagar, S., Shinagawa, K., Castellino, F. and Schorey, J.S. (2007) Exosomes Released from Macrophages Infected with Intracellular Pathogens Stimulate a Proinflammatory Response in vitro and in vivo. Blood, 110, 3234-3244. [Google Scholar] [CrossRef] [PubMed]
[19] Giri, P.K. and Schorey, J.S. (2008) Exosomes Derived from M. bovis BCG Infected Macrophages Activate Antigen- Specific CD4+ and CD8+ T Cells in Vitro and in Vivo. PLOS ONE, 3, e2461. [Google Scholar] [CrossRef] [PubMed]
[20] Ramachandra, L., Qu, Y., Wang, Y., et al. (2010) Mycobacte-rium Tuberculosis Synergizes with ATP to Induce Release of Microvesicles and Exosomes Containing Major Histo-compatibility Complex Class II Molecules Capable of Antigen Presentation. Infection and Immunity, 78, 5116-5125. [Google Scholar] [CrossRef] 
[21] Giri, P.K., Kruh, N.A., Dobos, K.M. and Schorey, J.S. (2010) Proteo-mic Analysis Identifies Highly Antigenic Proteins in Exosomes from M. tuberculosis-Infected and Culture Filtrate Pro-tein-Treated Macrophages. Proteomics, 10, 3190- 3202. [Google Scholar] [CrossRef] [PubMed]
[22] Kruh-Garcia, N.A., Schorey, J.S. and Dobos, K.M. (2012) Exosomes: New Tuberculosis Biomarkers Prospects from the Bench to the Clinic. In: Cardona, P.J., Ed., Understanding Tuberculosis, 395-410.
[23] Anand, P., Anand, E., Bleck, C., Anes, E. and Griffiths, G. (2010) Exosomal Hsp70 Induces a Pro-Inflammatory Response to Foreign Particles Including Myco-bacteria. PLOS ONE, 5, e10136. [Google Scholar] [CrossRef] [PubMed]
[24] Singh, P.P., Lemaire, C., Tan, J.C., Zeng, E.L. and Schorey, J.S. (2011) Exosomes Released from M. tuberculosis Infected Cells Can Suppress IFN-γ Mediated Activation of Naïve Macrophages. PLOS ONE, 6, e18564. [Google Scholar] [CrossRef] [PubMed]
[25] Pieters, J. (2008) Mycobacterium Tuberculosis and the Macro-phage: Maintaining a Balance. Cell Host & Microbe, 3, 399-407. [Google Scholar] [CrossRef] [PubMed]
[26] Banerjee, J., Roy, S., Dhas, Y. and Mishra, N. (2019) Senes-cence-Associated miR-34a and miR-126 in Middle-Aged Indians with Type 2 Diabetes. Clinical and Experimental Medi-cine, 20, 149-158. [Google Scholar] [CrossRef] [PubMed]
[27] Gareev, I., Beylerli, O., Yang, G., et al. (2020) The Current State of MiRNAs as Biomarkers and Therapeutic Tools. Clinical and Experimental Medicine, 20, 349-359. [Google Scholar] [CrossRef] [PubMed]
[28] Hu, Y., Lan, W. and Miller, D. (2017) Next-Generation Se-quencing for MicroRNA Expression Profile. In: Huang, J., et al. Eds., Bioinformatics in MicroRNA Research, Humana Press, New York, 169-177. [Google Scholar] [CrossRef] [PubMed]
[29] Zhou, X.H., Fang, S.Q., Wang, M., et al. (2019) Diagnostic Value of Circulating miRNA-122 for Hepatitis B Virus and/or Hepatitis C Virus-Associated Chronic Viral Hepatitis. Bi-oscience Reports, 39, BSR20190900. [Google Scholar] [CrossRef] 
[30] Peng, Z.L., Chen, L. and Zhang, H. (2020) Serum Proteomic Analysis of Mycobacterium Tuberculosis Antigens for Discriminating Active Tuberculosis from Latent Infection. Journal of In-ternational Medical Research, 48. [Google Scholar] [CrossRef] [PubMed]
[31] Ma, F., Xu, S., Liu, X.G., et al. (2011) The microRNA miR-29 Controls Innate and Adaptive Immune Responses to Intracellular Bacterial Infection by Targeting Interferon-γ. Nature Immunology, 12, 861-869. [Google Scholar] [CrossRef] [PubMed]
[32] Lin, J., Wang, Y., Zou, Y.Q., et al. (2016) Differential miRNA Expression in Pleural Effusions Derived from Extracellular Vesicles of Patients with Lung Cancer, Pulmonary Tuberculosis, or Pneu-monia. Tumor Biology, 37, 15835- 15845. [Google Scholar] [CrossRef] [PubMed]
[33] Dale, G. and Noren-berg, S. (1989) Time-Dependent Loss of Adenosine S’-Monophosphate Deaminase Activity May Explain Elevated Adenosine 5’-Triphosphate Levels in Senescent Erythrocytes. Blood, 74, 2157-2160.
[34] Zhang, D.F., Yi, Z. and Fu, Y.R. (2018) Downregulation of miR-20b-5p Facilitates Mycobacterium tuberculosis Survival in RAW 264.7 Macro-phages via Attenuating the Cell Apoptosis by Mcl-1 Upregulation. Journal of Cellular Biochemistry, 120, 5889-5896. [Google Scholar] [CrossRef] [PubMed]
[35] Morin, R.D., Bainbridge, M., Fejes, A., et al. (2008) Profiling the HeLa S3 Transcriptome Using Randomly Primed cDNA and Massively Parallel Short-Read Sequencing. BioTechniques, 45, 81-94. [Google Scholar] [CrossRef] [PubMed]
[36] Thomson, J.M., Parker, J., Perou, C. and Hammond, S.M. (2004) A Custom Microarray Platform for Analysis of microRNA Gene Expression. Nature Methods, 1, 47-53. [Google Scholar] [CrossRef] [PubMed]
[37] Chen, C.F., Ridzon, D., Broomer, A., et al. (2005) Real-Time Quantification of microRNAs by Stem-Loop RT-PCR. Nucleic Acids Research, 33, e179. [Google Scholar] [CrossRef] [PubMed]
[38] Schwarzenbach, H., da Silva, A.M., Calin, G. and Pantel, K. (2015) Data Normalization Strategies for MicroRNA Quantification. Clinical Chemistry, 61, 1333-1342. [Google Scholar] [CrossRef] [PubMed]
[39] Faraldi, M., Gomarasca, M., Sansoni, V., et al. (2019) Nor-malization Strategies Differently Affect Circulating miRNA Profile Associated with the Training Status. Scientific Reports, 9, Article No. 1584. [Google Scholar] [CrossRef] [PubMed]
[40] Benz, F., Roderburg, C., Vargas Cardenas, D., et al. (2013) U6 Is Unsuitable for Normalization of Serum miRNA Levels in Patients with Sepsis or Liver Fibrosis. Experimental & Mo-lecular Medicine, 45, e42. [Google Scholar] [CrossRef] [PubMed]

为你推荐